Anti-inflammatory treatments

Searching journal information continues to be the primary use of SciFinder for the medicinal chemist. One finds it especially useful for searching various topics, for instance, anti-inflammatory treatments. When performing structure/reaction-based searches, many chemists also use Beilstein CrossFire in conjunction with SciFinder. The reaction information from these systems is often complementary, and it is quite useful to have both SciFinder and CrossFire in a medicinal chemistry group. However, companies with restricted budget may have to choose one or the other. 

As reflected in another chapter of this volume, especially anti-inflammatory treatment by antihistamines, antileukotrienes or corticoids might influence the success of immunotherapies, because it normalizes and standardizes the immunological base of treatment [13]. In severe cases a reduction of IgE levels by anti-IgE antibodies or even a slight general immunosuppressive treatment may also be considerable [14],... 

Chan, B., Kalabalikis, P., Klein, N., Heyderman, R., and Levin, M. (1996). Assessment of candidate anti-inflammatory treatments on the interaction between meningococci and inflammatory cells in vitro i n awhole blood model. Biotherapy 9, 221-228. 

Over 100 million people worldwide suffer from asthma, and the most effective anti-inflammatory treatment of the disease is provided by glucocorticoids. 

Riedel, F., S.Naujukat, J.Ruschoff, S.Petzoldt, and C.H.Rieger. 1992. S(),-induced enhancement of inhalative allergic sensitization inhibition by anti-inflammatory treatment. Int. Arch. Allergy Immunol. 98(4) 386-391. 

Dachir, S., Fishheine, E., Meshulam, Y., Sahar, R., Amir, A., Kadar, T. (2002). Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model. Hum. Exp. Toxicol. 21 197-203. 

Norflus F, Nanje A, Gutekunst CA, Shi G, Cohen J, Bejarano M, Fox J, Ferrante RJ, Hersch SM (2004) Anti-inflammatory treatment witli acetylsalicylate or rofecoxib is not neuroprotective in Huntington s disease transgenic mice. Neurobiol Dis 17 319—325. 

A 36-year-old man with Crohn s disease became refractory to standard anti-inflammatory treatment (glucocorticoids, mercaptopurine, methotrexate, ciclosporin, tacrolimus) (33). Remission over 8 months was achieved with a single infusion of infliximab. With the onset of relapse he was given another infusion of infliximab and had an anaphylactic-Uke reaction within 1 minute. 

Exhaled nitric oxide was used as the marker of airway inflammation after patients who had asthma were found to have increased levels of exhaled nitric oxide and nitric oxide synthase expression [17]. Exhaled nitric oxide correlated with a response to steroid, defined as change in pulmonary function testing, asthma symptoms, and BHR [18]. Patients who have symptoms of asthma who respond to steroids have higher exhaled nitric oxide than those who do not, implying inadequate anti-inflammatory treatment. The cutoff of exhaled nitric oxide for steroid response was determined to be approximately 48 parts per billion in one study [18], but no standards are widely used. 

Pain is not only one of the cardinal characteristics of inflammation, but the most significant one in clinical inflammatory disease it is often the principal target of anti-inflammatory treatment. However, pain is often of noninflammatory origin and may be relieved, regardless of its origin, by agents acting in several different ways. 

Several issues are worthy of consideration when interpreting randomized trials of anti-inflammatory treatments and metabolic support for STEMI. A consistent pattern of a sound biological hypothesis and... 

Diabetes is associated with an increased chronic low-grade inflammatory state also affecting the coronary arteries [46]. In recent years there has been much attention on the possible effect of specific anti-inflammatory treatment of CHD. A large randomized trial stndying the effect of an anti-C5 complement antibody (pexelizumab) in a little less than 6,000 patients with STEMI has been disappointing as no tendency of a benefit could be demonstrated [47]. At present the issue of antiinflammatory treatment of chronic or acute CHD seems speculative. 

Detebioration of Asthma Asthma may deteriorate acutely over a period of hours or chronically over several days or longer. If the patient needs more doses of albuterol tablets than nsnal, this may be a marker of destabilization of asthma and reqnires re-evalnation of the patient and treatment regimen, giving special consideration to the possible need for anti-inflammatory treatment, for example, corticosteroids. 

Howard, K. A., Paludan, S. R., Behlkc, M. A., Besenbacher, R, Deleuran, B., Kjems, J. 2009. Chitosan/siRNA nanoparticles-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Mol. Ther. 17 162-168. 

Anti-TNFa mAbs are highly effective anti-inflammatory treatments although repeated treatments are necessary to maintain disease improvement. However, the duration of clinical improvement may progressively shorten with repeated treatments (29, 30) which may be the result of the anti-antibody response. 

Observational studies The short-term and long-term safety of topical bevacizumab 5 mg/ml for progressive corneal neovascularization secondary to a variety of corneal diseases and not responding to conventional anti-inflammatory treatment have been evaluated in 30 eyes of 27 patients Five patients (five eyes) developed new corneal epithelial defects. The authors warned against using bevacizumab in patients with epithelial defects and neurotrophic keratopathy. There were no allergic reactions, ocular drug-related complaints, or systemic adverse reactions. 

---